The BOADICEA model of genetic susceptibility to breast and ovarian cancer.
about
Genome-wide association study identifies novel breast cancer susceptibility lociMeta-analysis of BRCA1 and BRCA2 penetranceCommon genetic variation in candidate genes and susceptibility to subtypes of breast cancerMRI screening for breast cancer in women at high risk; is the Australian breast MRI screening access program addressing the needs of women at high risk of breast cancer?Distribution of BRCA1 and BRCA2 Mutations in Asian Patients with Breast CancerCharacterization of BRCA1 and BRCA2 mutations in a large United States samplePrevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer.Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized MedicineA focus group study on breast cancer risk presentation: one format does not fit allGenetic evidence and integration of various data sources for classifying uncertain variants into a single model.Selecting a BRCA risk assessment model for use in a familial cancer clinic.The prevalence of BRCA1 mutations among young women with triple-negative breast cancer.Age of onset in familial breast cancer as background data for medical surveillanceBreast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance.Pubertal development in girls by breast cancer family history: the LEGACY girls cohort.Eligibility for magnetic resonance imaging screening in the United Kingdom: effect of strict selection criteria and anonymous DNA testing on breast cancer incidence in the MARIBS Study.Efficiency of BRCAPRO and Myriad II mutation probability thresholds versus cancer history criteria alone for BRCA1/2 mutation detectionBreast cancer risk assessment using genetic variants and risk factors in a Singapore Chinese population.Familial relative risks for breast cancer by pathological subtype: a population-based cohort studyIncorporating tumour pathology information into breast cancer risk prediction algorithms.Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of LAMBDA, BRCAPRO, Myriad II, and modified Couch models.Genome-wide search for breast cancer linkage in large Icelandic non-BRCA1/2 families.Breast Cancer Risk - Genes, Environment and Clinics.Clinical software development for the Web: lessons learned from the BOADICEA project.BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.Hereditary cancer risk assessment: essential tools for a better approach.The construct of breast cancer risk perception: need for a better risk communication?Disease-specific prospective family study cohorts enriched for familial risk.Risk factor modification and projections of absolute breast cancer riskRisk prediction of complex diseases from family history and known susceptibility loci, with applications for cancer screening.Genetic testing for familial/hereditary breast cancer-comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany.BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients.Evaluation of the BOADICEA risk assessment model in women with a family history of breast cancer.Spatial analysis of county-level breast cancer mortality in Texas.A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effectsHigh prevalence of preinvasive lesions adjacent to BRCA1/2-associated breast cancers.A case-control study on risk factors of breast cancer in China.Efficient identification and referral of low-income women at high risk for hereditary breast cancer: a practice-based approach.Practical problems with clinical guidelines for breast cancer prevention based on remaining lifetime risk.Twenty-five years of breast cancer risk models and their applications
P2860
Q24645441-77C6EB6A-3910-44C7-8CC6-DA6A639B188AQ24654786-D29B8902-2AA6-4D80-8244-B582879825B6Q24658131-A1F8EA24-B6E5-4D36-BBBD-ADD8E32A92A6Q26785571-D17B1ECB-6034-41C1-8256-8C06D946B1DFQ27023165-4DF2F8F2-ADBE-4CBB-922C-91E05BF08431Q28383993-DF3683B3-A164-47EF-B052-2A0DDFF45B06Q30275554-BBBD74D4-4C86-47EC-A9EC-2B895A4212F7Q30513982-3D464A90-53F1-4D11-80C2-0023DE14A1C9Q30541811-13BA9801-CF9D-49B6-94AB-0BF6FBF1B81FQ33379396-EFE507DF-643C-47D6-B151-3BB3A3950DABQ33395135-4F5939D3-BB27-48D0-BFEB-4777E95D0499Q33419708-64CC39FC-793B-4452-BF6F-D439B18A9F01Q33515727-F146B3C6-017D-47C0-8FB6-463FB9BE6C2CQ33739374-AF96E1DA-AA2C-40D1-A1F9-0BC32836A704Q33781466-18415383-C0C7-456F-A586-790EBA2F177DQ33847327-E481DC9C-4D7B-49DE-B053-65B69A62C658Q33853726-31514204-3F58-4F6A-A297-5F28F3867A4AQ33892384-D11B05C8-2A32-4598-A07D-9C3528A10654Q33892928-1FF884BA-04BB-4C26-B0D9-76304BFC5247Q34048046-4F4AFF35-A947-46C5-823B-01291B1695F0Q34102617-243C2AD3-36F8-4307-83C7-7417431D3860Q34173446-397D3D67-F098-4ADD-A5B9-03AC64C2CB88Q34201805-12A2AC0D-7195-48FB-8358-EF0155785978Q34227099-B064E96D-5974-4288-A8E0-785F8A27C0B4Q34480647-8C4CA0EE-CB37-41C4-B9F7-D7F25E6214CCQ34507839-1AB57405-9A3A-4C16-AC63-FB35B718A196Q34608162-21425C4A-89DD-4A44-BDB8-209BA9EEE362Q34662485-CCA5ADDA-1D8C-4247-ACAF-DAF9FA8922AFQ35090578-8B348236-FF68-4A5A-BE75-85FB4D2A6191Q35136955-E010724B-482D-4AC9-BACA-F3C12B371274Q35263848-9A7C5DB9-8536-4FED-9506-C559C0899A3CQ35527158-3807550C-6E09-4D9F-AC91-820E0517D45AQ35815711-60D47F9D-802F-4822-8786-7B8D0F5EC6D6Q35838110-29856378-523E-40D9-BD1F-D30E20613C67Q35848518-DB2E3B97-A1AA-4B26-B694-740E805109FDQ35903769-D2C5CA36-449B-4DAE-A7E6-A309538F39D0Q35990459-71C79DCE-27A9-4211-8F52-171A31E54FF8Q35994562-19FF9E0D-01BE-4FFD-A6E5-82D51CB30B76Q36009831-10D527E4-2BDF-437D-A4D8-A9CCA8890C33Q36294980-1D7AE4B4-57FC-40E8-942B-3732A185285B
P2860
The BOADICEA model of genetic susceptibility to breast and ovarian cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The BOADICEA model of genetic susceptibility to breast and ovarian cancer.
@ast
The BOADICEA model of genetic susceptibility to breast and ovarian cancer.
@en
type
label
The BOADICEA model of genetic susceptibility to breast and ovarian cancer.
@ast
The BOADICEA model of genetic susceptibility to breast and ovarian cancer.
@en
prefLabel
The BOADICEA model of genetic susceptibility to breast and ovarian cancer.
@ast
The BOADICEA model of genetic susceptibility to breast and ovarian cancer.
@en
P2860
P356
P1476
The BOADICEA model of genetic susceptibility to breast and ovarian cancer.
@en
P2093
P P D Pharoah
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602175
P407
P577
2004-10-01T00:00:00Z